PTIX - Protagenic Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development417.866456.274456.274
Selling General and Administrative1,411.466568.764491
Non Recurring404.169404.169404.169
Total Operating Expenses---
Operating Income or Loss-2,233.501-1,025.038-491
Income from Continuing Operations
Total Other Income/Expenses Net-35.16313.0898
Earnings Before Interest and Taxes-2,268.664-1,011.949-483
Interest Expense7.16211.47318
Income Before Tax-2,275.826-1,023.422-501
Income Tax Expense---
Minority Interest---74
Net Income From Continuing Ops-2,275.826-1,023.422-476
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-2,275.826-1,023.422-476
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-2,275.826-1,023.422-476